The global single-use mixers market size is anticipated to reach USD 2.28 billion by 2030. The increasing need for biopharmaceuticals, increased environmental awareness, and the growing threat of cross-contamination are the main drivers of market expansion. In addition, the demand for single-use mixers (SUM) is also growing as a result of the widespread usage of single-use technology and the significant cost savings associated with installation and operation.
According to the IFPMA press release published in December 2021, nearly 11 billion COVID-19 vaccines were produced in the year 2021 and, approximately 24 billion were estimated to be produced by mid-2022. Furthermore, in February 2021, the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense (DoD) launched the "Operation Warp Speed" initiative to accelerate the development and distribution of COVID-19 vaccines and therapeutics. The initiative involved collaboration between the government, the biopharmaceutical industry, and other partners to expedite clinical trials and production of COVID-19 treatments. Hence, the collaboration between the government and the biopharma industry is anticipated to increase the production of vaccines for COVID-19, thus increasing the demand for the technology.
According to a BRUEGEL article, published in July 2021, The European Union is the largest producer worldwide of vaccines with annual vaccine production estimated at 15.5 million kilograms, followed by India with an estimation of 14.5 million kilograms. China comes in third with production between 8-12 million kilograms. Thus, the use of single-use technology for the development and production of medicines and vaccines is increasing since the demand for vaccines has significantly increased during and after the pandemic.
The SUM market's growth is constrained, nonetheless, by factors like leaching and extractable from SUM. Various disposable product manufacturers produce single-use mixers from various materials which include plastic, silicone, and rubber, which may leach and release potentially harmful chemicals and contaminants into the drug products being manufactured. Extractables are a significant concern in the biopharmaceutical industry, as they can impact the quality, safety, and efficacy of the drugs being manufactured. Furthermore, regulatory agencies such as the FDA require drug manufacturers to ensure that the levels of extractable in the products are below a certain threshold. Thus, by choosing materials carefully, testing rigorously, implementing strict quality control measures, and collaborating closely with clients and regulatory agencies, the leading players are working to ensure the efficacy of SUM while meeting the evolving needs of the biopharmaceutical industry.
This product will be delivered within 1-3 business days.
According to the IFPMA press release published in December 2021, nearly 11 billion COVID-19 vaccines were produced in the year 2021 and, approximately 24 billion were estimated to be produced by mid-2022. Furthermore, in February 2021, the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense (DoD) launched the "Operation Warp Speed" initiative to accelerate the development and distribution of COVID-19 vaccines and therapeutics. The initiative involved collaboration between the government, the biopharmaceutical industry, and other partners to expedite clinical trials and production of COVID-19 treatments. Hence, the collaboration between the government and the biopharma industry is anticipated to increase the production of vaccines for COVID-19, thus increasing the demand for the technology.
According to a BRUEGEL article, published in July 2021, The European Union is the largest producer worldwide of vaccines with annual vaccine production estimated at 15.5 million kilograms, followed by India with an estimation of 14.5 million kilograms. China comes in third with production between 8-12 million kilograms. Thus, the use of single-use technology for the development and production of medicines and vaccines is increasing since the demand for vaccines has significantly increased during and after the pandemic.
The SUM market's growth is constrained, nonetheless, by factors like leaching and extractable from SUM. Various disposable product manufacturers produce single-use mixers from various materials which include plastic, silicone, and rubber, which may leach and release potentially harmful chemicals and contaminants into the drug products being manufactured. Extractables are a significant concern in the biopharmaceutical industry, as they can impact the quality, safety, and efficacy of the drugs being manufactured. Furthermore, regulatory agencies such as the FDA require drug manufacturers to ensure that the levels of extractable in the products are below a certain threshold. Thus, by choosing materials carefully, testing rigorously, implementing strict quality control measures, and collaborating closely with clients and regulatory agencies, the leading players are working to ensure the efficacy of SUM while meeting the evolving needs of the biopharmaceutical industry.
Single-use Mixers Market Report Highlights
- Based on product, the consumables & accessories segment dominated in terms of the revenue share of 58.03% in 2022 attributing various advantages such as cost-effectiveness, customization of required accessories, and reducing disposable waste, thus increasing the demand in the market
- Based on application, the research and development (R&D) & process development segment dominated in terms of the revenue share of 65.41% in 2022 owing to the tractability, scalability, cost-effectiveness, and reproducibility provided by these systems. Thus, increasing the demand for the technology in this application segment
- Based on end use, the pharmaceutical & biotechnology companies segment dominates in terms of the revenue share of 43.06% in 2022. This is attributed to the major commercial success of biologics, as bio-manufacturers are the key end users of single-use technologies, including SUM
- In 2022, North America dominated with a revenue share of 36.09%, owing to the increase in the adoption of novel technologies and biopharmaceuticals in the region for the analysis and treatment of clinical ailments. Moreover, government initiatives are anticipated to increase the overall research and development centers, resulting in market growth
- Asia Pacific accounted for the fastest-growing region with a CAGR of 13.22% from 2023 to 2030. The growing investments in the biopharmaceutical industry is driven due to rising demand for vaccine production, thus, fueling the upsurge for single-use mixers industry.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Single - Use Mixers Market Variables And Trends
Chapter 4 Single - Use Mixers Market: Product Estimates & Trend Analysis
Chapter 5 Single - Use Mixers Market: Application Estimates & Trend Analysis
Chapter 6 Single - Use Mixers Market: End - User Estimates & Trend Analysis
Chapter 7 Single - Use Mixers Market: Regional Estimates And Trend Analysis
Chapter 10 Single - Use Mixers Market: Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Sartorius AG
- Danaher
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Meissner Filtration Products, Inc.
- DrM, Dr. Mueller AG
- Avantor, LLC
- CerCell A/S
- AGILITECH
- Holloway America, LLC.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.21 Billion |
| Forecasted Market Value ( USD | $ 2.28 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
